Literature DB >> 25141831

Randomized prospective trial comparing two supraglottic airway devices: i-gel™ and LMA-Supreme™ in paralyzed patients.

Nikola Joly1, Louis-Pierre Poulin, Issam Tanoubi, Pierre Drolet, François Donati, Patrick St-Pierre.   

Abstract

PURPOSE: Many features can influence the choice of a supraglottic airway device (SAD), including ease of insertion, adequate ventilation pressures and lack of adverse effects. The goal of this randomized prospective trial was to compare the performance of the i-gel™ with that of the LMA-Supreme™.
METHODS: One hundred adult patients (American Society of Anesthesiologists I-III) scheduled to undergo elective surgery under general anesthesia were randomized to either an i-gel (n = 50) or an LMA-Supreme (n = 50). The primary objective was to compare ventilation pressures. Secondary objectives included time and number of attempts needed to introduce the device, adverse effects, and repositioning. The endoscopic view of the glottic aperture and the position of the drain tubes in relation to the esophagus were also evaluated.
RESULTS: The devices were inserted successfully in 46 (92%) patients in both groups. There was no significant difference in the [mean (SD)] leak pressure [i-gel: 23 (7) cm H2O vs LMA-Supreme: 21 (8) cm H2O; P = 0.14] or peak inspiratory pressure between both devices. Insertion time was shorter with the i-gel than with the LMA-Supreme [19 (7) sec vs 27 (17) sec, respectively; P = 0.003]. The vocal cords were completely visualized more often through the i-gel (70%) than through the LMA-Supreme (50%) (P = 0.007). Esophageal mucosa was easily visualized through the drain port in all but four patients, two patients in each group. There was no difference between groups regarding preoperative or postoperative complications. Postoperative patient discomfort was generally mild and comparable between both devices.
CONCLUSION: Both the LMA-Supreme and the i-gel offer similar performance for positive pressure ventilation in paralyzed patients during general anesthesia. The i-gel was associated with a slightly faster insertion time and better fibrescopic visualization of the glottis. This trial was registered at Clinicaltrials.gov: NCT01001078.

Entities:  

Mesh:

Year:  2014        PMID: 25141831     DOI: 10.1007/s12630-014-0198-6

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  7 in total

1.  A preliminary assessment of the LMA protector™ in non-paralysed patients.

Authors:  Ban Leong Sng; Farida Binte Ithnin; Deepak Mathur; Eileen Lew; Nian-Lin Reena Han; Alex Tiong-Heng Sia
Journal:  BMC Anesthesiol       Date:  2017-02-20       Impact factor: 2.217

Review 2.  Airway Leads and Airway Response Teams: Improving Delivery of Safer Airway Management?

Authors:  Carolyn Smith; Alistair F McNarry
Journal:  Curr Anesthesiol Rep       Date:  2020-07-20

3.  A prospective, randomized comparison of the LMA-protector™ and i-gel™ in paralyzed, anesthetized patients.

Authors:  Jee-Eun Chang; Hyerim Kim; Jung-Man Lee; Seong-Won Min; Dongwook Won; Kwanghoon Jun; Jin-Young Hwang
Journal:  BMC Anesthesiol       Date:  2019-07-04       Impact factor: 2.217

4.  A Synopsis of Contemporary Anesthesia Airway Management.

Authors:  Christian Bohringer; James Duca; Hong Liu
Journal:  Transl Perioper Pain Med       Date:  2019-01-15

5.  Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults.

Authors:  C Frerk; V S Mitchell; A F McNarry; C Mendonca; R Bhagrath; A Patel; E P O'Sullivan; N M Woodall; I Ahmad
Journal:  Br J Anaesth       Date:  2015-11-10       Impact factor: 9.166

6.  Comparison of i-gel® and LMA Supreme® during laparoscopic cholecystectomy.

Authors:  Sang Yoong Park; Jong Cheol Rim; Hyuk Kim; Ji Hyeon Lee; Chan Jong Chung
Journal:  Korean J Anesthesiol       Date:  2015-09-30

7.  A comparison of i-gel™ and Laryngeal Mask Airway Supreme™ during general anesthesia in infants.

Authors:  Yoon Chan Lee; Kyoung Seop Yoon; Sang Yoong Park; So Ron Choi; Chan Jong Chung
Journal:  Korean J Anesthesiol       Date:  2017-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.